Vident Advisory’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,848
| Closed | -$265K | – | 1499 |
|
|
2024
Q2 | $265K | Sell |
10,848
-1,603
| -13% | -$39.2K | 0.01% | 1171 |
|
|
2024
Q1 | $265K | Sell |
12,451
-351
| -3% | -$7.48K | 0.01% | 1095 |
|
|
2023
Q4 | $245K | Buy |
12,802
+721
| +6% | +$13.8K | 0.01% | 1114 |
|
|
2023
Q3 | $194K | Buy |
+12,081
| New | +$194K | 0.01% | 1126 |
|